Zhu Xiaoyun, Belmont Heather J, Price-Schiavi Shari, Liu Bai, Lee Hyung-il, Fernandez Marilyn, Wong Richard L, Builes Janette, Rhode Peter R, Wong Hing C
Altor BioScience Corp., Miramar, FL 33025, USA.
J Immunol. 2006 Mar 1;176(5):3223-32. doi: 10.4049/jimmunol.176.5.3223.
Intracellular Ags are processed into small peptides that are presented on cell surfaces in the context of HLA class I molecules. These peptides are recognized by TCRs displayed by CD8+ T lymphocytes (T cells). To date, direct identification and quantitation of these peptides has relied primarily on mass spectrometry analysis, which is expensive and requires large quantities of diseased tissues to obtain useful results. Here we demonstrate that multimerization of a soluble single-chain TCR (scTCR), recognizing a peptide from p53 presented in the context of HLA-A2.1, could be used to directly visualize and quantitate peptide/MHC complexes on unmanipulated human tumor cells. Tumor cells displaying as few as 500 peptide/MHC complexes were readily detectable by flow cytometry. The scTCR/multimers exhibited exquisite recognition capability and could distinguish peptides differing in as little as a single amino acid. We also demonstrate that scTCR/multimers could specifically stain human tumors generated in mice, as well as tumors obtained from patient biopsies. Thus, scTCR/multimers represent a novel class of immunostaining reagents that could be used to validate, quantitate, or monitor epitope presentation by cancer cells.
细胞内抗原被加工成小肽,这些小肽在HLA I类分子的背景下呈递在细胞表面。这些肽被CD8 + T淋巴细胞(T细胞)所展示的TCR识别。迄今为止,这些肽的直接鉴定和定量主要依赖于质谱分析,该方法昂贵且需要大量患病组织才能获得有用结果。在这里,我们证明了识别在HLA - A2.1背景下呈递的来自p53的肽的可溶性单链TCR(scTCR)的多聚化可用于直接可视化和定量未处理的人类肿瘤细胞上的肽/MHC复合物。通过流式细胞术很容易检测到显示低至500个肽/MHC复合物的肿瘤细胞。scTCR/多聚体表现出出色的识别能力,能够区分仅相差一个氨基酸的肽。我们还证明了scTCR/多聚体可以特异性地染色小鼠体内产生的人类肿瘤以及从患者活检中获得的肿瘤。因此,scTCR/多聚体代表了一类新型的免疫染色试剂,可用于验证、定量或监测癌细胞的表位呈递。